Arkolith/Insider Trading/CASI/Form 4

He Wei-Wu

Chairman and CEO, Director, 10% OwnerCASI Pharmaceuticals, Inc. (CASI) · full profile →Form 4 · filed Jun 17, 2022
Net Buying
Open-Market Buys
$273K
Open-Market Sells
$0
Net Open-Market Flow
$273K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2022Buy(P)50K$3.18$159K645K
Jun 14, 2022Buy(P)2K$3.06$6K595K
Jun 13, 2022Buy(P)36K$2.97$107K592K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-072392) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML